Inhibiting a protein associated with chronic inflammation improves lung health in mice with COVID-19. Helena Kudiabor, Nature A signalling molecule that helps to kick-start inflammation in the lungs could play a key part in aggravating some long COVID symptoms, finds a study that analysed lung samples from people with the condition. The findings, published in Science Translational Medicine on […]
Inhibiting a protein associated with chronic inflammation improves lung health in mice with COVID-19. Helena Kudiabor, Nature A signalling molecule that helps to kick-start inflammation in the lungs could play a key part in aggravating some long COVID symptoms, finds a study that analysed lung samples from people with the condition. The findings, published in Science Translational Medicine on […]
Tuğba Çiçek • Melahat Uzel Sener • Ayperi Öztürk, Published:, 2024, DOI: 10.7759/cureus.64678 Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to high morbidity and mortality rates worldwide. It is known that some patients, initially hospitalized in general wards, deteriorate over time and require advanced respiratory support (ARS). This study […]
Authors: A.R. Stasyshyn , .S. Stadnyk, A.I. Doroshak,I et. al., (Medical perspectives) 27(1):86-91 DOI:10.26641/2307-0404.2022.1.254332 Abstract Acute mesenteric circulatory disorder belongs to the most serious diseases of the abdominal cavity. Being an emergency condition, it is associated with high mortality. Coronavirus infection is an anthroponotic disease in the group of acute respiratory infections, is characterized by damage […]
Marika Mdivnishvili • Darejan Mdinaradze • Ketino Virkovi • George Gogashvili, Published: July 05, 2024DOI: 10.7759/cureus.63876 Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a global health crisis. Long COVID refers to a debilitating condition characterized by severe symptoms that may arise after the initial acute phase of COVID-19. Significant attention has […]
Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos, et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to fatal outcomes. Characterizing DAD pathophysiology across disease progression is of ultimate importance to better understand the molecular and cellular features driving different DAD patterns and […]
Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1 , et. al., Front. Immunol., 27 February 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have […]
Ghada E. Elgarawany • Sapna Shevade • Shahad Aldebi • Bader Ahmed • Fagr Omer • Raghad Adel, Published: June 06, 2024, DOI: 10.7759/cureus.61773 Cite this article as: Elgarawany G E, Shevade S, Aldebi S, et al. (June 06, 2024) Evaluation of Pulmonary Function in Post-convalescent COVID-19 Adults: A Comparative Insight. Cureus 16(6): e61773. doi:10.7759/cureus.61773 Abstract Background and objective COVID-19 is a respiratory disease that is highly contagious and […]
MAY 31, 2024 – Authored by Megan Redshaw, J.D. Epoch Times SARS-CoV-2 infection may cause severe pulmonary conditions such as pneumonia, inflammation, and acute respiratory distress syndrome, but until now, researchers have not understood the driving force behind lung damage caused by COVID-19. In a recently published paper in Nature Communications, researchers at Columbia University discovered […]
Mohini Asija • Shaveta Dahiya • Rohit Parsad • Sanjay Fotedar • Rohit Sharma • Vikas Bhatthi May 28, 2024, DOI: 10.7759/cureus.61221 Abstract Introduction The coronavirus disease 2019 (COVID-19) pandemic has impacted the lives of thousands of patients worldwide with many patients having residual symptoms months after the acute infection. The severity of lung involvement ranges from mild asymptomatic to severe acute respiratory distress syndrome (ARDS), […]